Autonomic Nervous System (ANS) Cholinergic Drugs 4 أ0م0د.وحدة بشير اليوزبكي.

Slides:



Advertisements
Similar presentations
INDIRECT CHOLINOMIMETICS Pharmacology Department
Advertisements

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 15 Cholinesterase Inhibitors and Their Use in Myasthenia Gravis.
Myasthenia Gravis Dr. Belal M. Hijji, RN. PhD February 29, 2012.
Muscle weakness Index case Year 1 Michaelmas Term.
INDIRECT CHOLINOMIMETICS
Agents Used to Treat Musculoskeletal Health Alterations.
Therapeutic Plasma Exchange for Myasthenia Gravis Clifford Blieden, MD Houston Methodist Hospital Department of Pathology and Genomic Medicine, Division.
 Myasthenia gravis is a chronic autoimmune neuromuscular disease that is characterized by different degrees of weakness of the skeletal muscles of the.
Pharmacology-1 PHL 313 Parasympathetic Nervous System Sixth Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacology-1 PHL 313 Parasympathetic Nervous System Third Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacology DOR 101 Abdelkader Ashour, Ph.D. 5 th Lecture.
ANTICHOLINERGIC DRUGS Pharmacology Department
NEUROMUSCULAR JUNCTION BLOCKERS BY :DR ISRAA OMAR.
Cholinergic agonists & Cholinergic antagonists
Cholinergics, anticholinergics and antcholinesterases Nervous System Peripheral NS Sensory nerves Motor nerves Central NS (Brain and Spinal cord) Sensory.
GENERAL THORACIC SURGERY CHAPTER 168
Cholinergic agonists By Dr.Sajid Hussain
Myasthenia Gravis.  Describe myasthenia gravis  Signs and Symptoms of the disease  Describe the treatments available Purpose and Objectives.
MYASTHENIA GRAVIS (MG)
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Myasthenia Gravis Victor Politi,M.D.
Asmah Nasser, M.D.. M1Secretory glands salivation, stomach acid, sweating, lacrimation M2HeartDecreases heart rate  bradycardia M3Smooth muscle (GI/GU/Resp)
MYASTHENIA GRAVIS ANESTHESIOLOGY Jasdeep Dhaliwal Clinical Rotation.
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
Medical and Surgical Management of MG Brian A. Crum, MD Department of Neurology Mayo Clinic Rochester, MN MGFA National Meeting, St. Louis May, 2010.
Pharmacology-1 PHL 351, Parasympathetic Nervous System Abdelkader Ashour, Ph.D. 6 th Lecture.
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
INDIRECT CHOLINOMIMETICS
NEUROMUSCULAR JUNCTION BLOCKERS
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 19 Cholinergic Drugs.
Cholinergic drugs.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 20 Cholinergic Drugs.
ANTICHOLINERGIC DRUGS
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
Pharmacology-1 PHL 211 Twelfth Lecture By Abdelkader Ashour, Ph.D. Phone:
ANTICHOLINESTERASES Acetylcholinesterase is an enzyme that specifically cleaves acetylcholine to acetate and choline. It is located both pre-and post-synaptically.
Drugs Affecting the Autonomic Nervous System
Myasthenia Gravis.
Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
Neurology Chapter of IAP
INDIRECT CHOLINOMIMETICS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
By Pharmacist Salwan Salem  -Central nervous system (CNS)  - Peripheral nervous system (PNS)  *CNS: spinal cord and brain  *The PNS consists.
Autonomic Nervous System 6-Anticholinergic Drugs
MYASTHENIA GRAVIS Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital.
MYASTHENIA GRAVIS “FROM WEAKNESS SHALL COME STRENGTH”. BY PATTI HAMILTON.
Dr: Samah Gaafar Al-shaygi بسم الله الرحمن الرحيم.
Autonomic Nervous System Anticholinergic Drugs- 5
Dr. Carl B. Goodman Professor of Pharmacology Florida A&M University College of Pharmacy & Pharmaceutical Sciences 308E FSH-SRC
INDIRECT CHOLINOMIMETICS Prof. Hanan Hagar Pharmacology Department.
Myasthenia Gravis.
Neuromuscular disorders
INDIRECT CHOLINOMIMETICS Pharmacology Department
INDIRECT CHOLINOMIMETICS
CHOLINESTERASES ANTICHOLINESTERASES PROPERTIES AND USES
Autonomic nervous pharmacology 2
Cholinesterase Inhibitors (Indirect acting cholinergic agonists)
School of Pharmacy, University of Nizwa
Neurotransmitters SOMATIC NERVOUS SYSTEM Striated ACh muscle
“Grave Muscle Weakness”
Cholinergic Antagonist
Cholinergic Antagonist
School of Pharmacy, University of Nizwa
Chapter 6 Muscarinic [,mʌskə‘rinik]毒蕈碱的 receptor agonists
INDIRECT CHOLINOMIMETICS
Intro to Neuromuscular blocking agents
inDirect Cholinomimetics
Cholinesterase inhibitors
Cholinesterase inhibitors
Cholinergic drugs.
Presentation transcript:

Autonomic Nervous System (ANS) Cholinergic Drugs 4 أ0م0د.وحدة بشير اليوزبكي

Objectives At end of this lecture, the students should be able to: 1- Identify myasthenia gravis (pathogenesis, diagnosis & treatment). 2- Enumerate drugs induced disorders of N-M transmission. 3- State clinical indications of the cholinergic drugs (agonists) in general. 4- Discuss adverse reactions of all the cholinergic drugs. - At a level consistence with standards scientific curriculum for the College of Medicine/ University of Mosul.

Myasthenia Gravis It is a disease affecting neuromuscular junctions of skeletal muscle. Pathogenesis: - Clinical features of MG are caused by special autoimmune antibodies (Abs), which either block or causes lyses of the Ach receptors. - Cholinoceptors exist for about 7days in normal individuals but for only 1day in MG patient. - The thymus gland is in some way involved in the pathogenesis as 75% of the patients have either thymitis or a thymoma.

Symptoms of myasthenia gravis - The characteristic symptoms of weakness and fatigability that decrease with rest and worsen with exercise, may affect any skeletal muscle but most often involve the small muscles of the head, neck, and extremities. - Frequent findings are ptosis, diplopia, difficulty in speaking and swallowing & extremity weakness. - Severe disease may affect all the muscles, including muscles necessary for respiration.

myasthenia gravis Diagnosis of - Edrophonium is used as a diagnostic test for MG. 2 mg dose is injected IV after baseline measurements of muscle strength have been obtained. If no response occurs after 45 seconds, an additional 8 mg may be injected. - If the patient has MG an improvement in the strength of muscles last for 15 minutes ( this differentiate MG from cholinergic crisis due to excessive drug therapy in which there will be worsening of the condition).

myasthenia gravis Treatment of 1- Chronic long-term therapy of MG is usually accomplished with neostigmine, pyridostigmine. Notes: a- The doses are titrated to optimum levels based on changes in muscle strength. b- These agents are relatively short-acting and therefore require frequent dosing (every 2-4 hours, for neostigmine and every 3-6 hours for pyridostigrnine). ?

c- If muscarinic effects of such therapy are prominent, they can be treated by atropine (antimuscarinic drugs) d- Longer-acting cholinesterase inhibitors such as the organophosphorous agents are not used. ?? because the dose requirement in this disease changes too rapidly to permit smooth control with these drugs.

myasthenia gravis Treatment of 2- Thymectomy should be done once the clinical state allows and if there is no powerful contraindication to surgery. 3- Adreno corticosteroid, (prednisolone), induce improvement in 80% of cases. 4- Immunosuppressive therapy. Aim is to eliminate Ach. Receptor Abs. Azathioprine may be used as steroid-sparing agent.

Drug induced disorders of N-M Transmission 1- Antibiotics: - Ammoglycosides (streptomycin, gentamycin) - polypeptides (colistin, polymyxin B) - polypeptides (colistin, polymyxin B) - Quinolones (ciprofloxacin). 2- C.V.S: - Quinidine, procainamide, lignocaine -B-blockers e.g propranolol; oxprenolol. 3- Other drugs: pencillamine, phenytoin, Lithium.

Clinical indications of the cholinergic drugs (agonists) They have 4 main clinical indications: 1. Reduce IOP in patients with glaucoma and during ocular surgery. 2. Treatment of atony of (GIT & bladder). 3. Diagnose & treatment of myasthenia gravis. 4. Minor uses: as antidotes to: a- Neuromuscular blocking agents (muscle relaxants), tubocurarine. b- Drugs with anticholinergic effects such as tricyclic antidepressant, belladonna alkaloid. Note: Tacrine: The newest anticholinesterase agent used for treatment of mild to moderate dementia associated with Alzheimer's disease.

Adverse Reactions of all the cholinergic drugs 1. On eye : blurred vision, decrease accommodation and meiosis. 2. On skin : Increase sweating. 3. On GIT : Increase salivation, belching, nausea, vomiting, intestinal cramps (abdominal colic) and diarrhea.

4. On CVS : vasodilatation, decrease heart rate (bradycardia). 5. At motor end plate : hyperpolarization of the skeletal muscle which will reduce contraction. 6. On CNS : irritability, anxiety and fear, some of them causes seizures.